NO782571L - Antibakterielle sammensetninger. - Google Patents

Antibakterielle sammensetninger.

Info

Publication number
NO782571L
NO782571L NO782571A NO782571A NO782571L NO 782571 L NO782571 L NO 782571L NO 782571 A NO782571 A NO 782571A NO 782571 A NO782571 A NO 782571A NO 782571 L NO782571 L NO 782571L
Authority
NO
Norway
Prior art keywords
approx
acceptable salt
pharmaceutically acceptable
trimethoprim
phosphanilic acid
Prior art date
Application number
NO782571A
Other languages
English (en)
Norwegian (no)
Inventor
Georg Redl
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO782571L publication Critical patent/NO782571L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO782571A 1977-07-27 1978-07-26 Antibakterielle sammensetninger. NO782571L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/819,523 US4125610A (en) 1977-07-27 1977-07-27 Antibacterial compositions

Publications (1)

Publication Number Publication Date
NO782571L true NO782571L (no) 1979-01-30

Family

ID=25228386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782571A NO782571L (no) 1977-07-27 1978-07-26 Antibakterielle sammensetninger.

Country Status (20)

Country Link
US (1) US4125610A (el)
JP (1) JPS5444037A (el)
AU (1) AU520488B2 (el)
BE (1) BE869319A (el)
CA (1) CA1093969A (el)
CH (1) CH636523A5 (el)
DE (1) DE2833014A1 (el)
DK (1) DK332278A (el)
FI (1) FI782319A7 (el)
FR (1) FR2398500A1 (el)
GB (1) GB2001527B (el)
GR (1) GR72424B (el)
IE (1) IE47715B1 (el)
IL (1) IL55210A (el)
IT (1) IT1107232B (el)
LU (1) LU80038A1 (el)
NO (1) NO782571L (el)
PH (1) PH14512A (el)
SE (1) SE7808114L (el)
ZA (1) ZA784193B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386952B (de) * 1979-04-26 1988-11-10 Bristol Myers Co Verfahren zur herstellung von antibakteriellen mischungen
CA1159834A (en) * 1979-04-26 1984-01-03 Paul L. Warner, Jr. Chlorhexidine salts and compositions of same
US4708952A (en) * 1985-02-06 1987-11-24 Aida Salatinjants Method of treatment of the infectious and viral diseases by one time interference
US5200402A (en) * 1991-10-24 1993-04-06 U.S. Army Medical Research & Development Command Anti microbial mafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor
GB0803948D0 (en) * 2008-03-03 2008-04-09 Habbal Magdi E Combination therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159573A (en) * 1961-03-30 1964-12-01 Smith Corp A O Resistance sensing probe system
BE793253A (fr) * 1971-12-23 1973-04-16 Lepetit Spa Nouvelles compositions bactericides et leur utilisation

Also Published As

Publication number Publication date
CA1093969A (en) 1981-01-20
IT1107232B (it) 1985-11-25
IE781509L (en) 1979-01-27
JPS5444037A (en) 1979-04-07
LU80038A1 (fr) 1979-04-09
GB2001527B (en) 1982-01-20
AU3819178A (en) 1980-01-24
IT7850441A0 (it) 1978-07-24
IL55210A (en) 1982-05-31
US4125610A (en) 1978-11-14
DE2833014A1 (de) 1979-02-15
AU520488B2 (en) 1982-02-04
FI782319A7 (fi) 1979-01-28
FR2398500B1 (el) 1980-10-31
IL55210A0 (en) 1978-09-29
SE7808114L (sv) 1979-01-28
CH636523A5 (de) 1983-06-15
DK332278A (da) 1979-01-28
FR2398500A1 (fr) 1979-02-23
BE869319A (fr) 1979-01-29
IE47715B1 (en) 1984-05-30
PH14512A (en) 1981-08-24
GR72424B (el) 1983-11-04
ZA784193B (en) 1979-07-25
GB2001527A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
JP5709354B2 (ja) ｍＴＯＲ阻害剤投与によるがん患者の治療
NO156373B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
US11679097B2 (en) Combination product containing limonoid compound and biguanide compound
WO2013070606A1 (en) Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
NO782571L (no) Antibakterielle sammensetninger.
US20230225977A1 (en) Formulation comprising daprodustat
US6242424B1 (en) Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
Paul et al. Topics in clinical pharmacology: ganciclovir
CN102295609B (zh) 2-[(取代苯氨基)羰基甲硫基]-6-环己甲基-3h-嘧啶-4-酮类化合物、其合成方法及用途
KR20020041451A (ko) 세포내 원핵생물, ｄｎａ 바이러스 및 레트로바이러스에의한 감염을 치료하기 위한 3-히드록시-4-피론의 갈륨착물
US3852450A (en) Antibacterial compositions containing rifampicin and a pyrimidine derivative
Shokry et al. Malignant melanotic neuroectodermal tumor of infancy: a case report
NO315928B1 (no) Anvendelse av en anilidforbindelse for fremstilling av et profylaktisk eller terapeutisk middel for behandling av type I allergiske sykdommer
US2823163A (en) Antivaginitis process and cation exchange resin composition
UA82564C2 (uk) Антиретровірусна фармацевтична композиція керованого вивільнення та спосіб її виготовлення
CN115192593B (zh) 柔红霉素在治疗多重耐药菌感染疾病中的应用
JPH04275221A (ja) 制癌効果増強剤
Kassab DEVELOPMENT OF NOVEL ANTIMICROBIAL TETRACYCLINE ANALOG B (IODOCYCLINE) BY CHEMO-INFORMATICS.
JPS6036409B2 (ja) 微生物感染処置用組成物
US5763419A (en) Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphate
US5118799A (en) Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
CN101845052B (zh) 一类含氮杂环的噻吩并吡啶酮衍生物、其制备方法和用途
De Koning et al. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
Robinson et al. Severe diarrhea secondary to propranolol
EP0291488A2 (en) Erythromycin derivative and the preparation and use thereof